Sangamo Biosciences, Inc. (SGMO) Reports In-Line Q4 EPS Loss of $0.12
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $3.41 million.
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c
- Zscaler (ZS) Tops Q4 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
